Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05790928 · ClinicalTrials.gov registry record

Air Optix Night and Day Aqua (AONDA) Retrospective Study 1

A clinical trial of Myopia and Hyperopia, sponsored by Alcon Research.

Completed
Registry status
108
Enrollment target
4
Study locations

NCT05790928 is a study of Myopia and Hyperopia that has completed, run by Alcon Research. The registered enrollment target is 108 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (60% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05790928, a study of Myopia and Hyperopia, has completed, sponsored by Alcon Research.

COMPLETED
Registry status
108 participants
Enrollment target
4
Study locations

Study Summary

The purpose of this study is to assess long term performance and safety of AONDA in a real world setting when worn as daily wear or continuous wear for vision correction. This study will be used to support AONDA's marketability in Europe and other locations.

Interventions

  • DEVICE Lotrafilcon A spherical contact lenses

Study Locations (4)

Florida

  • Tallahassee Eye Center - Tallahassee

Illinois

  • Franklin Park Eye Center PC - Franklin Park

Minnesota

  • The Eye Doctors Inc - Eden Prairie

Tennessee

  • Optometry Group, PLLC - Memphis

Trial Details

FieldValue
Enrollment Target 108 participants
Start Date 2023-03-25
Est. Completion 2023-03-31

Sponsor

Alcon Research

275 total trials

What the Registry Record Tells You About NCT05790928

The ClinicalTrials.gov registry entry for NCT05790928 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (60% lower). The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Myopia appearing as the primary indexed condition, and to 1 intervention - of which Lotrafilcon A spherical contact lenses is the first listed.

NCT05790928 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Florida, Illinois, Minnesota.

Frequently Asked Questions

What is clinical trial NCT05790928 about?

NCT05790928 is a clinical study titled "Air Optix Night and Day Aqua (AONDA) Retrospective Study 1". The purpose of this study is to assess long term performance and safety of AONDA in a real world setting when worn as daily wear or continuous wear for vision correction. This study will be used to support AONDA's marketability in Europe and other locations.

What is the current status of trial NCT05790928?

This trial is currently completed. The enrollment target is 108 participants. The study started on 2023-03-25. Estimated completion is 2023-03-31.

What conditions does trial NCT05790928 study?

This clinical trial studies the following conditions: Myopia, Hyperopia, Refractive Ametropia.

What interventions are being tested in trial NCT05790928?

The interventions under investigation include: Lotrafilcon A spherical contact lenses (DEVICE).

Who is sponsoring clinical trial NCT05790928?

This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05790928 being conducted?

This trial has 4 study locations across Florida, Illinois, Minnesota, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.